Antifungal nanoparticles may help burn victims

07/2/2013 | SkinAndAllergyNews.com

Nanoparticle-encapsulated amphotericin b significantly reduced fungal biofilm activity in a burn wound model, compared with an untreated control model, researchers found. AmB-np also resulted in more advanced re-epithelialization, organized dermal proliferation and appropriate dermal remodeling compared with solubilized AmB and an untreated control model, according to the study in Nanomedicine: Nanotechnology, Biology, and Medicine. AmB can be toxic to the liver at high doses and encapsulating it might reduce toxicity and allow topical burn treatment, the researchers said.

View Full Article in:

SkinAndAllergyNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC